<DOC>
	<DOCNO>NCT00185328</DOCNO>
	<brief_summary>To evaluate safety , tolerability , efficacy Angeliq Thai post menopausal woman hot flush climacteric symptom .</brief_summary>
	<brief_title>Efficacy Tolerability Angeliq Thai Women</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>Postmenopausal woman hot flush Women contraindication Hormone Replacement Therapy ( HRT )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Postmenopause</keyword>
</DOC>